Evoq Remedies: The Low-Cost Stock with a High-Value Order of Rs.136 Crore CMP Rs.16.71

By -

Evoq Remedies Share Company: A Pharmaceutical Powerhouse


Evoq Remedies Share Company, a prominent trader in the pharmaceutical raw materials sector, has recently made headlines with a new order worth Rs 136 crore. This significant development, coupled with a 20% return to investors over the past six months, underscores the company's robust performance and promising future.

Trading in Essential Raw Materials


Evoq Remedies' portfolio is diverse, encompassing nutritional vitamins, amino acids, dairy products, solvents, pellets, and excipients. These raw materials are fundamental to the pharmaceutical industry, underscoring the company's pivotal role in this sector. The company's registered corporate office and storage location are situated in Ahmedabad, Gujarat, a strategic location for its operations.

Current Financial Status


A glance at the company's current financial status reveals a debt of Rs 9.58 crore. However, the promoters' holding stands strong at 73.53%. The company has demonstrated a sales growth of 21.49%, and its total market cap is Rs 26.44 crore. Impressively, the profit growth is recorded at 48.38%, indicating a healthy financial trajectory.

Performance Review: 2023


The year 2023 was a roller-coaster ride for Evoq Remedies. The stock touched its 50-week low level of Rs 18.49 and also set a 52-week high level of Rs 10.50. Despite these fluctuations, the company managed to yield an 18% return to investors over the year. In the last three months and one month, the company has given returns of 12% and 29% respectively to the investors, showcasing its resilience and potential for growth.

A Major Export Order


Adding to its list of achievements, Evoq Remedies has secured an export order worth Rs 136 crore from Marlex Pharma. This order includes high-quality pharmaceutical products such as metformin API, tramadol hydrochloride API, Omeprazole Powder, and cefoxitin sodium sterile. This order not only boosts the company's financial standing but also reinforces its reputation for delivering high-quality pharmaceutical products.

In conclusion, Evoq Remedies Share Company continues to make strides in the pharmaceutical sector, promising a bright future for its investors and stakeholders.

Keywords: Evoq Remedies, Pharmaceutical Raw Materials, Rs.136 Crore Order, Stock Below Rs.20, Pharma Company, Ahmedabad Gujarat, Promoters’ Holding, Sales Growth, Profit Growth, Market Cap, 50-Week Low, 52-Week High, Investor Returns, Export Order, Marlex Pharma, Metformin API, Tramadol Hydrochloride API, Omeprazole Powder, Cefoxitin Sodium Sterile

Comments

Post a Comment

Popular posts from this blog

Deccan Gold Mines Up 150% in a Year, Makes Major Lithium Move in Mozambique

By -
Image
The country's only listed gold exploration and mining company Deccan Gold Mines Limited (DGML) acquired majority stake in 5 lithium blocks in Mozambique, Africa  Deccan Gold Mines Limited (DGML), India's sole listed gold exploration and mining company, has recently made a significant move that has caught the attention of investors worldwide. The company has acquired a majority stake in five lithium blocks in Mozambique, Africa, positioning itself within the globally recognized Alto Ligonha pegmatite belt, known for its abundant reserves of lithium-cesium-tantalum (LCT) pegmatites. {jistoc} $title={Table of Contents} A Strategic Acquisition This acquisition is crucial for the mining of lithium, tantalum, and beryllium. The critical mineral concession block has been procured through Deccan Gold FZCO, a wholly-owned subsidiary of DGML. DGFZCO will hold a majority ownership stake of 51% in DGMOZ, with the potential for this ownership to increase to 70% in the near...
Read more

Small Cap Gem: Sakuma Exports Doubles in 2024, Bonus Share Proposal on July 1st?

By -
Image
Sakuma Exports: A Smallcap Stock with Big Returns in 2024 In the world of stock trading, smallcap stocks often go unnoticed. However, one such stock has been making waves in the Indian stock market - Sakuma Exports Ltd. This company, engaged in the buying, processing, marketing, exporting, and importing of agricultural products, has seen its share price double in the calendar year 2024. {jistoc} $title={Table of Contents} A Stellar Performance As of Thursday, June 20, the Sakuma Exports stock price has recorded a nearly 100% year-to-date gain , hitting the day’s high of ₹37.86 apiece on the NSE. This impressive performance is not a sudden phenomenon but the result of a strong run over the past couple of months. The company's shares have been on a steady upward trajectory, reflecting the positive sentiment among investors. The surge in the stock price is a testament to the company's robust business model and its ability to deliver consistent growth. Bonus Issue ...
Read more

Simple Investing: It's Not Rocket Science (But It Takes More Than Luck)

By -
Image
Successful Investing: Simple, But Not Easy Disclaimer:  This blog post is for informational purposes only and should not be taken as financial advice. Always do your own research and consider seeking advice from a certified financial advisor before making any investment decisions. {jistoc} $title={Table of Contents} The Myth of Easy Wealth The bull market of the 1990s created a myth that the stock market was essentially a high-return savings account. This belief was fueled by the ease of access to financial information and the ability to trade stocks online. However, as many investors discovered when the bubble burst, if something looks too good to be true, it usually is. Investing requires more than just opening an online account and watching financial news. It requires a deep understanding of the market, the ability to analyze and interpret financial data, and the discipline to stick to your investment strategy even when the market is volatile. It also requires...
Read more